COMPANY INSIGHT

Sponsored by Gerteis

Gerteis® – More than three decades passion for Roller Compaction

Gerteis Maschinen + Processengineering AG is a Swiss-based company that has established itself as world leader in the field of premium roller compactors. The company’s products and services cover all aspects of dry granulation processes, with unparalleled experience in this field built up since the company was founded in 1986.

Your Dry Granulation Experts!

The success of the company can be ascribed to a variety of reasons, not least of which are the values at the core of the enterprise; the reliability, sustainability and quality of its machines are the foundation of the company's good reputation. Partnered with a dedication to service and customer satisfaction, Gerteis® is committed to maintaining the level of excellence it has cultivated so far.

Looking back at the earliest years when the company was still a one-man-business, Paul Gerteis remembers the challenges of starting off in a field that already had long-established enterprises competing for a share in the market. His background in sales of pharmaceutical equipment provided Gerteis with an in-depth knowledge of the needs of his future customers and in what he calls a lucky coincidence he found a way to make roller compaction a viable and advantageous option for processing most substances. The development of the patented Gerteis compaction technology was only the first step in founding what is now a market-leading company. Customers had to be won and they were impressed by the numerous unique benefits offered by the Gerteis® roller compaction systems. It is in these early days that Paul Gerteis set the standard for the excellent customer service that the company still prides itself on today. “It was my personal commitment to serving the customer to the best of my ability that opened the doors to many of the companies we still supply today,” says Paul Gerteis in an interview. Word of mouth helped him establish his company which has seen a continuous growth since its founding days.

Visit Gerteis at Achema 2018!

Choosing a Gerteis® roller compactor is a long-term investment with some machines having been in use for more than two decades. This longevity is coupled with a high sustainability since the dry granulation process is a very energy-efficient and fast method to achieve a homogeneous granulate. The patented roller technology employed by all Gerteis compactors allows for a uniform consistency in the product and handles all products with the utmost care during the compaction process. Thanks to WIP (Wash in Place) and CIP (Clean in Place) systems available as part of most compactor series, down time needed for cleaning can be kept to a minimum. The CIP system in combination with Gerteis’ bespoke containment system ensures a high level of protection for the operators against dangerous substances.

To ensure the best possible service Gerteis is in constant exchange with engineers, scientists and suppliers to remain up-to-date with current trends, requirements and innovations. This translates into reliable expertise in finding optimal solutions for their customers' production issues and increasing the existing output by optimising processes. Their customised designs are tailored to the needs of each customer and in-house training courses assure that operators are capable of handling and servicing the machines. Thanks to regional partners Gerteis is able to resolve maintenance issues and problems quickly and efficiently.

2018 will be an exciting year for Gerteis with a first outstanding customer events taking place in June. From 11 to 15 June trade fair ACHEMA takes place in Frankfurt, Germany, an excellent opportunity to meet with industry’s key stakeholders in R&D, production and engineering to discuss new solutions and share insights.

Three roller compactors will be placed on booth to represent Gerteis’ abilities to serve different customer requirements and allowing visitors to get a hands-on experience:

  • MINI-PACTOR®: A high containment roller compactor designed for R&D applications and the most stringent GMP requirements, utilizing a unique feed and force control system, large diameter rolls and a superior punch & die designed compaction roll system. The Mini Pactor® line is capable of producing from 10 grams of product up to 100kg/hr continuous production.
    New control features allowing language switch, giving global flexibility to multinational enterprises.
  • MACRO-PACTOR®: The choice for full production! A high containment roller compactor using the technical features of the Mini-Pactor with a production capacity of up to 400 kilograms an hour, again while maintaining OEL down to 3µg/m³ as standard.
  • Polygran®: The Polygran® compactor can produce up to 300kg/hr by using similar control systems as the larger Pactor® Series, different roller surfaces and easily interchangeable screens for maximized output efficiency.

Attendees are cordially invited to visit the Gerteis stand in Hall 3.0 Booth D25 where they can observe the roller compactors in action, running dry powder processing demonstrations throughout the event.

Go to article: Home | An (in)active pill problemGo to article: EditorialGo to article: SHL Group Company InsightGo to article: Scandinavian HealthGo to article: ContentsGo to article: NSFGo to article: NewsGo to article: AlmacGo to article: Covid-19 executive briefing by GlobalDataGo to article: Gerteis Company InsightGo to article: GerteisGo to article: Digital biomarkers are emerging as important predictive tools to support the gloGo to article: Accurate Biometrics Company Insight Go to article: Accurate BiometricsGo to article: Almost 70 potential Covid-19 drug and experimental compound candidates identifiedGo to article: Datwyler Company Insight Go to article: DatwylerGo to article: Risk assessment of Covid-19 on patients suffering from IBDGo to article: Zenatek Go to article: The pharma industry briefingGo to article: FargoGo to article: Another bump in the road for mumps treatmentGo to article: Last TechnologyGo to article: From Covid-19 to SARS: what becomes of the whistleblowers?Go to article: ButterworthGo to article: Peptomyc: the quest for a ‘universal’ cancer treatmentGo to article: Q&A: is pharma ready to address the health effects of climate change?Go to article: Modality SolutionsGo to article: Not-so-inactive ingredients: a sore spot for patients?Go to article: Beyond M&As: will 2020 be the year of the spin-off? Go to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Q&A with Genocea: improving cancer treatment with precise, personalised targetsGo to article: MimotopesGo to article: Pharma Playbook: an inside look at Signals Analytics vast therapeutic database Go to article: ILC Dover Go to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue